ArticleACS omega2025
Decoding E-Cigarette Secrets: Unveiling Saliva and E-Liquid Composition through Fourier-Transform Infrared Spectroscopy.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Electronic cigarettes (e-cigs), initially introduced as smoking cessation aids, have given rise to a new wave of nicotine dependence. A critical question that has emerged is the potential adverse effects of e-cig use on oral health, particularly how the vapor emitted from these devices may alter the salivary composition of users. Here, we investigate the salivary composition of e-cig users and analyze the e-liquids (flavorings) using Fourier-transform infrared (FTIR) spectroscopy. Saliva samples were categorized into two groups: e-cigarette users (25 individuals) and nonsmokers/nonusers (25 individuals). Additionally, 26 e-liquid samples used by the e-cig users were collected, with 17 obtained before use and 9 after use. The analysis provided reliable results in distinguishing between the two groups. Notably, partial least-squares discriminant analysis (PLS-DA) demonstrated a high degree of accuracy (>90%) in differentiating the sample groups. Our findings revealed a higher concentration of polysaccharides, aromatic amino acids, and inorganic phosphates, along with a lower concentration of esterases in the saliva of e-cigarette users. These alterations in salivary composition may be linked to an increased risk of type 2 diabetes, hypertension, cardiovascular diseases, kidney diseases, and tumor formation, having a negative impact on oral immunity. In contrast, no significant molecular or compositional changes were observed in the e-liquids after use. Our results underscore the importance of continued research into potential biomarkers and the long-term health effects associated with the growing prevalence of e-cigarette use as a form of nicotine consumption.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.